Timber Pharmaceuticals Says Proposal To Approve Merger Agreement Was Not Approved By A Majority Of Outstanding Shares Of Common Stock Entitled To Vote; Held Special Meeting To Vote On Matters Like Adopt Plan Of Merger With Leo US, Leo Spiny Merger Sub
Timber Pharmaceuticals Says Proposal To Approve Merger Agreement Was Not Approved By A Majority Of Outstanding Shares Of Common Stock Entitled To Vote; Held Special Meeting To Vote On Matters Like Adopt Plan Of Merger With Leo US, Leo Spiny Merger Sub
Timber Pharmicals表示，批准合併協議的提案未獲得大多數有權投票的已發行普通股的批准；舉行特別會議，就通過與利奧美國合併計劃、Leo Spiny Merger Sub等事項進行投票
Timber Pharmaceuticals Says Proposal To Approve Merger Agreement Was Not Approved By A Majority Of Outstanding Shares Of Common Stock Entitled To Vote; Held Special Meeting To Vote On Matters Like Adopt Plan Of Merger With Leo US, Leo Spiny Merger Sub
Timber Pharmicals表示，批准合併協議的提案未獲得大多數有權投票的已發行普通股的批准；舉行特別會議，就通過與利奧美國合併計劃、Leo Spiny Merger Sub等事項進行投票
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。